|
|
TTD Drug ID:
DNC004448
Drug
Information |
Name | (3-Bromo-phenyl)-quinazolin-4-yl-amine | Indication | Not Available | Experimental | Structure |
Click to save drug structure in 3D MOL format
Click to save drug structure in 2D MOL format
| InChI | 1S/C14H10BrN3/c15-10-4-3-5-11(8-10)18-14-12-6-1-2-7-13(12)16-9-17 -14/h1-9H,(H,16,17,18) | InChIKey | SUTRLYZWRGPLSJ-UHFFFAOYSA-N | Canonical SMILES | C1=CC=C2C(=C1)C(=NC=N2)NC3=CC(=CC=C3)Br | Target | Epidermal growth factor receptor erbB1 |  | Inhibitor | [1] | Ref 1 | J Med Chem. 1996 Feb 16;39(4):918-28.Tyrosine kinase inhibitors. 9. Synthesis and evaluation of fused tricyclic quinazoline analogues as ATP site inhibitors of the tyrosine kinase activity of the epidermal growth factor receptor. To Reference |
Welcome
to sign our Guestbook.
If you
find any error in data or bug in web service, please kindly report it
to Dr.
Zhu.
Dr.
Chen Yuzong
Deputy Director of Center
for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore
All rights reserved.
|